Tata Consultancy Services' Connected Clinical Trials, Part of the TCS ADD Suite, Received the Recognition for its Technology Excellence in Clinical Research and Drug Development.
Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting, and business solutions organization, announced that its TCS Connected Clinical Trials (CCT) platform has won the 2020 Citeline Award in the category 'Best Patient-facing Technology Initiative'. CCT won the award for providing a positive experience to patients participating in clinical trials as well as unlocking superior efficiencies in the overall clinical trials process for sponsors, sites, and niche providers.
The awards, presented by Informa Pharma Intelligence, honor the achievements of those working to advance the quality of human healthcare worldwide by contributing toward bringing new and needed medicines to market. The nominations went through a rigorous review by an independent panel of volunteers from the top echelons of all sectors of the clinical R&D industry, who used their deep knowledge to score entries against the judging criteria.
Part of the TCS ADD platform, CCT is an innovative, cloud-based platform that enables real-time data integration, data-driven analytics and personalized patient support through smart technologies, wearables and mobile apps. It provides end-to-end visibility at patient and site level and lays the foundation for decentralized trials. The platform comprises patient and site engagement, supply management and devices, and connections capabilities.
'With COVID-19 significantly impacting clinical trials, life sciences industries, empowered with technology, are transitioning to a state of decentralized or virtual trials that eliminate the inefficiencies linked with the traditional site-centric approach and embed clinical trials into the daily lives of patients,' said Debashis Ghosh, Business Group Head, Life Sciences and Healthcare, TCS. 'This award validates our focus on providing life sciences organizations with novel technologies and broad cross-stakeholder partnerships to enable decentralized trials, thereby significantly enriching patient engagement, and enhancing test protocol adherence and outcomes.'
'This year's digital event showcased the remarkable innovation, commitment and achievement present across the industry. We are incredibly proud to provide the opportunity to recognize those working in pharma and related industries to drive medical breakthroughs and enhance human health,' said Karen Currie, Executive Director, Citeline. 'While the format of the event is virtual this year, the same high standards of excellence in clinical research and drug development are evident in the achievements of this year's winners including TCS Connected Clinical Trials.'
About TCS ADD platform
TCS ADD is a modern & open drug development platform for life sciences that enables digital ecosystems, simplifies data complexity and provides faster access to new and effective drugs for patients in need. The platform is powered by a cognitive artificial intelligence engine called TCS Decision Fabric, data driven smart analytics and Internet of Things (IoT) that makes clinical trials more agile and safe. TCS ADD leverages the best of cloud architecture and personalized user experience design in compliance with quality guidelines and privacy regulations.
To know more about the TCS ADD Life Sciences platforms, please visit https://www.tcs.com/advanced-drug-development or write to us at ADD.Platforms@tcs.com
About Tata Consultancy Services Ltd. (TCS)
Tata Consultancy Services is an IT services, consulting and business solutions organization that has been partnering with many of the world's largest businesses in their transformation journeys for over 50 years. TCS offers a consulting-led, cognitive powered, integrated portfolio of business, technology and engineering services and solutions. This is delivered through its unique Location Independent AgileTM delivery model, recognized as a benchmark of excellence in software development.
A part of the Tata group, India's largest multinational business group, TCS has over 443,000 of the world's best-trained consultants in 46 countries. The company generated consolidated revenues of US $22 billion in the fiscal year ended March 31, 2020, and is listed on the BSE (formerly Bombay Stock Exchange) and the NSE (National Stock Exchange) in India. TCS' proactive stance on climate change and award-winning work with communities across the world have earned it a place in leading sustainability indices such as the Dow Jones Sustainability Index (DJSI), MSCI Global Sustainability Index and the FTSE4Good Emerging Index. For more information, visit us at www.tcs.com
For TCS global news, follow @TCS_News.
TCS ADD Media Contact
Phone: +1 561 865 3339
Phone: +91 2267326147
TCS Media Contacts
Phone: +65 9138 4370
Australia and New Zealand
Phone: +61 422 989 682
Phone: +31 615 903387
Phone: +1 647 790 7602
Phone: +91 22 6778 9960
Middle East & Africa
Phone: +81 80 2115 0989
Phone: +569 6170 9013
Phone: +44 20 3155 2421
Phone: +1 203 984 3978
Middle East & Africa
Middle East & Africa